Inventor · disambiguated record
Tomoko Oda
Also filed as: ODA TOMOKO
10 granted patents·12 pending applications·17 citations·filing 2004–2023
84Inventor score
Top patents by PatentIndex Score
22 records- 0193US11419880B2Ursodeoxycholic acid-containing agent for treating or preventing presbyopiaSANTEN PHARMACEUTICAL CO LTD·Filed 2021·Granted Aug 23, 2022·2 cites·9 claims
- 0289US10435379B2[4-(1,3,3-trimethyl-2-OXO-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2018·Granted Oct 8, 2019·5 cites·9 claims
- 0389US10189796B2[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1H-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 29, 2019·6 cites·26 claims
- 0483US11612590B2Therapeutic agent for meibomian dysfunctionSANTEN PHARMACEUTICAL CO LTD·Filed 2019·Granted Mar 28, 2023·1 cites·3 claims
- 0581US11951098B2Therapeutic agent for meibomian dysfunctionSANTEN PHARMACEUTICAL CO LTD·Filed 2023·Granted Apr 9, 2024·0 cites·12 claims
- 0678US8017775B21-2-dihydroquinoline derivative having glucocorticoid receptor binding activitySANTEN PHARMACEUTICAL CO LTD·Filed 2006·Granted Sep 13, 2011·3 cites·35 claims
- 0772US12510536B2Method for changing condition of eyelid of hairless animalSANTEN PHARMACEUTICAL CO LTD·Filed 2020·Granted Dec 30, 2025·0 cites·4 claims
- 0872US2023040386A1Ursodeoxycholic acid-containing agent for treating or preventing presbyopiaSANTEN PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0969US2022072012A1Ursodeoxycholic acid-containing agent for treating or preventing presbyopiaSANTEN PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1064US2018246081A1Method for changing condition of eyelid of hairless animalSANTEN PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 1163US2019359577A1[4-(1,3,3-trimethyl-2-oxo-3,4-dihydro-1h-quinoxalin-7-yl)phenoxy]ethyloxy compound or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1261US12290497B2Agent containing 4-phenylbutyrate, for preventing or treating presbyopiaSANTEN PHARMACEUTICAL CO LTD·Filed 2019·Granted May 6, 2025·0 cites·6 claims
- 1358US2015125394A1Method for changing condition of eyelid of hairless animalSANTEN PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 1458US2016022648A1Therapeutic agent for meibomian gland dysfunctionSANTEN PHARMACEUTICAL CO LTD·Filed 2014·Application pending·0 cites
- 1556US2018021314A1Therapeutic agent for meibomian dysfunctionSANTEN PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
- 1655US2023346744A1Sulfur-containing compound useful for treating or preventing presbyopiaSANTEN PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1754US2024148755A1Water-based pharmaceutical composition containing ursodeoxycholic acid or salt thereofSANTEN PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1846US8420635B2Method for preventing or treating a glucocorticoid receptor-related diseaseMATSUDA MAMORU·Filed 2011·Granted Apr 16, 2013·0 cites·34 claims
- 1946US2022151989A1Lipoic acid prodrugSANTEN PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2044US10143761B2Method for changing condition of an eyelid for evaluation of an eyelid disease involving plugging of meibomian gland orifices and/or telangiectasia by administration of complete freund's adjuvantSANTEN PHARMACEUTICAL CO LTD·Filed 2013·Granted Dec 4, 2018·0 cites·7 claims
- 2143US2006258703A1Remedy for pruritus comprising piperidine derivative as the active ingredientONO PHARMACEUTICAL CO·Filed 2004·Application pending·0 cites
- 2237US2008119498A1Therapeutic Agent for Pruritus Comprising P38 Map Kinase Inhibitor as the Active IngredientKATO MASATOMO·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tomoko Oda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →